SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001572407-13-000002
Filing Date
2013-03-19
Accepted
2013-03-19 10:27:56
Documents
1
Period of Report
2013-03-03

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2093
  Complete submission text file 0001572407-13-000002.txt   3732
Mailing Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581
Business Address 1500 WEST PARK DRIVE SUITE 210 WESTBOROUGH MA 01581 (508) 767-3861
RXi Pharmaceuticals Corp (Issuer) CIK: 0001533040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1 KENDALL SQUARE BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139
Business Address 1 KENDALL SQUARE BUILDING 200 SUITE 2203 CAMBRIDGE MA 02139 720-936-6628
Advanced RNA Technologies, LLC (Reporting) CIK: 0001572407 (see all company filings)

State of Incorp.: CO | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 000-54910 | Film No.: 13700134